Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM
Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM
Following formative work, the proposed study is an open-label, pilot, randomized, two arm trial where subjects will receive pre-exposure prophylaxis (PrEP) for 6 months and either a cognitive-behavioral based adherence intervention or health education with supportive counseling.
Inclusion Criteria:
Exclusion Criteria: